Real-World Effectiveness of Human Papillomavirus Vaccination Against Vulvovaginal High-Grade Precancerous Lesions and Cancers | Zendy

Christian Dehlendorff | Zendy; Louise Baandrup | Zendy; Susanne K. Kjær | Zendy

Open Access

Real-World Effectiveness of Human Papillomavirus Vaccination Against Vulvovaginal High-Grade Precancerous Lesions and Cancers

Author(s) -

Christian Dehlendorff,

Louise Baandrup,

Susanne K. Kjær

Publication year - 2020

Publication title -

jnci journal of the national cancer institute

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.797

H-Index - 356

eISSN - 1460-2105

pISSN - 0027-8874

DOI - 10.1093/jnci/djaa209

Subject(s) - medicine , hazard ratio , genital warts , confidence interval , gynecology , incidence (geometry) , cumulative incidence , cohort , vaginal cancer , obstetrics , proportional hazards model , vaccination , hpv infection , cervical cancer , cancer , immunology , physics , optics

Vaccination against human papillomavirus (HPV) has proven to be effective against severe cervical lesions and genital warts, whereas no previous study has provided real-world data on the HPV vaccine effectiveness against high-grade vulvovaginal lesions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research